Psych Drugs
Drug Safety Issues: Psychotropic Drugs
Antidepressants shown worthless for most consumers
Nursing Homes: Psychotropic Drug Abuse
In the first half of the twenty-first century, U.S. psychiatrists are prescribing the second generation neuroleptics—Zyprexa, Risperdal, Geodon, Seroquel, Abilfy—to coerce innocent children and the elderly into submission.
Read MoreFDA Approves Another Dangerous Antipsychotic, Asenapine
At the July 30, 2009 FDA advisory committee hearing, the only formal presentations at the meeting were a summary of the safety and efficacy data by the sponsor.
Read MoreMarketing Trumps Safety: the case of Antipsychotics
"The story’s pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale.
Read MoreAntidepressants-Paxil, Prozac, Zoloft Increase Risk of Breast Cancer
Inexplicably, the FDA has dragged its feet about adding a warning label to both tamoxefin and the antidepressants, Paxil, Prozac and Zoloft–despitethe unanimous recommendation of its own advisory panel in 2006.
Read MoreJapan Revises SSRI Warnings–Hostility, Violence
The Japanes Ministry of Health, Labor and Welfare has investigated news reports about antidepressant users "who developed increased feelings of hostility or anxiety, and have even committed sudden acts of violence against others."
Read MoreTitle: FDA Approves Antipsychotic With Long History of Failure
The FDA has just approved the anitpsychotic drug, Fanapt (iloperidone) for adults with schizophrenia.
The drug, iloperidone, has a long history of failure. http://en.wikipedia.org/wiki/Iloperidone :
FDA-AstraZeneca Hearing
Seroquel Victim Asked Judge to Unseal Documents
Why is FDA Silent? Seroquel Victim Asked Judge to Unseal Documents for FDA Advisory
Read MoreADHD Drugs Induce Hallucinations in Kids–FDA safety Officers
Three years have elapsed since FDA medical officers reported the findings of their comprehensive review of clinical trial data at an FDA pediatric advisory committee hearing (March, 2006).
Read MorePatients Deserve Facts Re: Antipsychotic Drug
"There is altogether too much secrecy in court cases that implicate public health."
Read MoreRolling Stone – Marketing a Phony “Miracle” Drug
“Bitter Pill” by Ben Wallace-Wells in the current issue of Rolling Stone is an excellent, informative, in-depth article providing an overview into the pharmaceutical industry’s immensely successful—albeit illegal—aggressive marketing tactics, for selling a particularly unsafe, dangerous class of drugs—the antipsychotics, Zyprexa in particular.
Read More